IDO1 and cancer: In wild type mice, IL-30-silencing in PC–SLCs, markedly prevents intratumoral infiltration of immunosuppressive IDO+CD11b+Gr-1+ myeloid cells [95], hinders cancer proliferation and vascularization, and reduces lung metastatization.